脑部放疗，上午比下午敏感许多！
6 b/ ^' t, Z+ A" l8 ]2 e4 s
& p) A) D3 `9 j4 o- f" z& n. b0 }5 @9 @/ T! G* L7 M
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.0 F8 P, }* r! A2 h" {, q
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
" O2 F' t7 t$ D7 wRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
' y9 e' f( K7 k% ]5 f4 J. x* dSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.( X+ J6 a3 ^# B* Q" E0 u
* N4 @3 {( E# c
Abstract: z4 @$ i6 s" X8 q) X0 X9 [% K, V
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
9 i# @ M1 |5 ], C) b& w- H" q. C' l% Y2 T, k2 ~
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.' R2 g. t5 f# A, z+ [6 a z6 `
& ^- m/ G1 y$ K* C+ K2 ZRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
3 F: m) s& x- d- p6 \- E. b8 ]: Q9 I; B0 `
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
% c3 p/ t. |) H( C7 |( r5 C$ k$ K7 M# n0 R) r2 }
|
9 V8 C2 w2 q8 k; [9 T2 |
显身卡
